Does Menopause Cause Hair Loss? Evidence and Treatment

Does menopause cause hair loss? Yes, it can contribute to thinning, but it doesn’t explain every new change. Falling ovarian estrogen may alter hair cycling. Age and inherited follicle sensitivity can also reveal female pattern hair loss. Sudden shedding, bare patches, scalp pain, or a receding band need other explanations considered. Identify the pattern before choosing treatment. Menopausal hormone therapy is not a proven stand-alone hair-loss fix.

Does menopause cause hair loss?

Gupta and colleagues wrote in Maturitas in 2025 that scalp follicles respond to estrogen. Hormone fluctuations may change hair density, strand width, texture, and growth cycling. The review also found several hair disorders reported more often after menopause. These include female pattern hair loss, telogen effluvium, and frontal fibrosing alopecia.

That is an association, not proof that falling estrogen caused your hair loss. In 2022, Chaikittisilpa’s team examined 178 postmenopausal women in Thailand aged 50 to 65 using standardized photos and trichoscopy. They identified female pattern hair loss in 52.2%. Yet the study was cross-sectional, covered one population, and had no matched premenopausal control group.

Age, genes, recent illness, weight change, medicines, iron status, and thyroid function can overlap with the menopausal transition. Timing alone cannot sort them out. A cause-specific plan makes more sense than a serum marketed for menopause.

The pattern changes the next step

Start with what changed, where it changed, and how fast. This table is a decision aid, not a diagnostic test.

Decision table for hair changes around menopause

What you notice	Possible category	Useful next step	Important limit
A middle part widening slowly, with thinner hair across the top	Female pattern hair loss	Compare the distribution with this guide to crown thinning in women, then arrange a clinical assessment	A photo cannot confirm follicle miniaturization or its cause
Many full-length hairs shedding from across the scalp	Telogen effluvium or another diffuse shedding process	List recent illness, major stress, weight change, and new medicines for your clinician	Pattern loss and shedding can occur together
Short pieces at different lengths, with frayed or split ends	Hair-shaft breakage	Use the shedding-versus-breakage check and reduce damaging heat or tension	Less breakage improves retained length, not follicle density
A band-like frontal recession with eyebrow loss, redness, itch, pain, or burning	Possible frontal fibrosing alopecia	Seek a prompt dermatology assessment	This can scar follicles, so cosmetic tracking should not delay care

Photos show distribution, not cause. If the front edge is changing, a photo-based hairline change check can help you compare its visible outline. Keep the angle, hair position, and lighting consistent. The tool cannot identify menopause, inspect follicles, or measure treatment response.

Which treatments have the best evidence?

Topical minoxidil has the strongest trial support for pattern loss

A 2016 Cochrane review by van Zuuren and colleagues included 47 studies and 5,290 women. Across six studies, 26.5% of minoxidil users reported moderate-to-marked regrowth, versus 13.9% with placebo. Four direct comparisons found no clear benefit from 5% over 2%. Only five trials had low risk of bias; 26 were unclear and 16 high.

Lucky and colleagues ran a 48-week randomized trial in 381 women aged 18 to 49 with female pattern hair loss. Both 2% and 5% topical minoxidil improved hair counts over placebo. The 5% group beat placebo on all three primary outcomes. It also had more itching, local irritation, and unwanted hair growth.

The trial appeared in the Journal of the American Academy of Dermatology in 2004. It did not study postmenopausal women. The result supports minoxidil for the diagnosed condition, not a special menopause mechanism or a promise of full regrowth.

The British Association of Dermatologists’ 2024 guidance says benefit may take at least six months. It also notes that an early shed can occur during the first four to six weeks. Any benefit requires continued treatment. Ask a pharmacist or doctor whether topical minoxidil suits you, and follow the current local label.

Correct an identified trigger, not a guessed deficiency

Diffuse shedding needs a different plan. A clinician may review your medicines, recent health, diet, weight change, thyroid symptoms, blood count, and iron stores. Carmina and colleagues’ 2019 multidisciplinary report describes female pattern hair loss assessment as mainly clinical. It recommends checking for androgen excess and considering selected laboratory tests.

Do not treat a suspected deficiency from hair appearance alone. If iron is the concern, the evidence guide to low ferritin and hair loss explains why the lab result and wider clinical picture both matter. Correcting a real cause may help. Taking a mixed “hair vitamin” cannot establish that cause.

Prescription options depend on the diagnosis

Clinicians sometimes consider oral anti-androgen medicines for female pattern hair loss after assessing risks and contraindications. The trial results are not interchangeable. Price and colleagues randomized 137 postmenopausal women aged 41 to 60 to finasteride 1 mg daily or placebo for one year. Hair counts and blinded photographs showed no benefit from that studied regimen.

That negative trial does not prove every prescription option fails. It does show why copying a treatment plan designed for men is poor logic. Discuss prescription choices with a dermatologist rather than changing any medicine yourself.

Hormone therapy is not an established hair-regrowth treatment

Farkas and colleagues screened 1,715 records for a 2026 systematic review; only 13 studies met its criteria. Most had moderate to substantial methodological limits, and results varied. The review did not support routine topical or systemic estrogen for hair loss. Zouboulis and colleagues reached the same practical point in Climacteric in 2022.

Hormone therapy may still be appropriate for other menopause symptoms after an individual risk-benefit discussion. Do not start, stop, or change it because of shedding without speaking to the prescriber.

How long should you wait for a result?

Judge follicle treatment in months, not wash days. For topical minoxidil, six months is the earliest fair review point in the British guidance. The 2004 randomized trial assessed its main outcomes at 48 weeks. Week-to-week mirror checks mostly capture styling, oil, humidity, and lighting.

Take baseline photos only if they help you stay objective. Use the same part, camera distance, angle, and dry-hair state. Review them at a pre-set interval with your clinician. If thinning keeps progressing, revisit the diagnosis instead of stacking more products.

Recovery from diffuse shedding follows a different clock because it depends on the trigger. The guide to how long telogen effluvium lasts explains why shedding and visible density recover at different times. Progressive loss deserves earlier assessment because some conditions become harder to treat as follicles shrink or scar.

When should you see a doctor?

Book an assessment for persistent shedding, a widening part, or thinning that continues to progress. Go sooner for discrete bald patches, eyebrow loss, or a smooth and shiny strip of scalp. Pain, burning, redness, heavy scale, sores, or pus also need direct examination.

The British Association of Dermatologists warns that band-like frontal recession with eyebrow loss may be frontal fibrosing alopecia. This is a scarring condition. Once inflammation destroys a follicle, hair cannot regrow there, so waiting for menopause to finish is the wrong test.

Tell the clinician about fatigue, unexpected weight change, new facial hair, or other symptoms that arrived with the shedding. Bring a medication and supplement list, your timeline, and comparable photos. That gives the clinician more useful evidence than a bag of shed hairs.